Adesis Announces Expansion at Delaware’s DuPont Experimental Station
September 07 2021 - 4:15PM
Business Wire
Adesis, Inc., a leading contract research organization and a
wholly-owned subsidiary of Universal Display Corporation
(Nasdaq:OLED), today announced a new state-of-the-art laboratory
expansion to support its growing research and development pipeline.
Situated in Wilmington, Delaware, this expanded lab space
approximately triples Adesis’ footprint in the DuPont Experimental
Station.
“The new lab expansion in the Experimental Station increases our
research footprint and broadens our capabilities for discovering,
developing and designing critical chemistry solutions,” said Andrew
Cottone, Ph.D., President of Adesis, Inc. “For nearly a century,
the DuPont site has contributed to Delaware’s reputation as a
leader in chemical research and development, and we are proud that
Adesis is part of that remarkable legacy.”
“Adesis has a strong track record of growth and innovation, and
we are pleased to see their continued expansion at the Experimental
Station,” said Governor John Carney. “This is another example of
how Delaware remains a great place for businesses of all sizes to
put down roots, grow, and create jobs.”
The Adesis team worked closely with the office of Gov. John
Carney and Becky Harrington and Kurt Foreman at the Delaware
Prosperity Partnership (DPP), who were integral in facilitating the
search and securing the Experimental Station agreement. This
increased capacity will allow Adesis to extend its expertise and
service offerings across a broader range of opportunities.
“Supporting Adesis’ growth in Delaware has been very gratifying
for the DPP team to be a part of. As a leading chemical contract
research manufacturing and R&D organization, Adesis plays an
important role in enhancing Delaware’s vibrant science sector,”
said Kurt Foreman, President and CEO of Delaware Prosperity
Partnership. “Andrew Cottone and his team are doing great work. We
look forward to celebrating Adesis’ continued growth.”
Cottone continued, “This expansion is the result of the
continued growth Adesis has experienced since we first moved into
the Experimental Station in 2017 for additional laboratory space.
We’re incredibly appreciative of state and local support, including
Governor Carney, the DPP, and Delaware Innovation Space (DISI) CEO
and President, William Provine.”
About Adesis, Inc.
As a wholly-owned subsidiary of Universal Display Corporation,
Adesis is a contract research organization (CRO) supporting the
pharma, biotech, catalysis and a number of other industries. The
CRO specializes in organic and organometallic synthesis, in
milligrams to multi-kilogram quantities. Adesis has a business
model of providing clients with organic chemistry services in three
areas: early stage research, scale up and development, and
specialty manufacturing. With over 20 years of success and
approximately 100 chemists with extensive industry and professional
experience, Adesis supports companies in various industries with
small molecule organic chemistry expertise. Adesis provides a range
of services that can supplement research and development efforts.
It can also act as a specialty manufacturer to reinforce supply
chains and protect sensitive intellectual property. To learn more
about Adesis, please visit http://adesisinc.com/.
About Universal Display Corporation
Universal Display Corporation (Nasdaq: OLED) is a leader in the
research, development and commercialization of organic light
emitting diode (OLED) technologies and materials for use in display
and solid-state lighting applications. To learn more about
Universal Display Corporation, please visit https://oled.com.
Universal Display Corporation and the Universal Display
Corporation logo are trademarks or registered trademarks of
Universal Display Corporation. All other company, brand or product
names may be trademarks or registered trademarks.
All statements in this document that are not historical, such as
those relating to the Company’s technologies and potential
applications of those technologies, the Company’s expected results
and future declaration of dividends, as well as the growth of the
OLED and CRO market and the Company’s opportunities in that market,
are forward-looking financial statements within the meaning of the
Private Securities Litigation Reform Act of 1995. You are cautioned
not to place undue reliance on any forward-looking statements in
this document, as they reflect Universal Display Corporation’s
current views with respect to future events and are subject to
risks and uncertainties that could cause actual results to differ
materially from those contemplated. These risks and uncertainties
are discussed in greater detail in Universal Display Corporation’s
periodic reports on Form 10-K and Form 10-Q filed with the
Securities and Exchange Commission, including, in particular, the
section entitled “Risk Factors” in Universal Display Corporation’s
Annual Report on Form 10-K for the year ended December 31, 2020.
Universal Display Corporation disclaims any obligation to update
any forward-looking statement contained in this document.
(OLED-C)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210907005769/en/
Adesis, Inc./ Universal Display Corporation Contact:
Darice Liu investor@oled.com media@oled.com +1 609-964-5123
Universal Display (NASDAQ:OLED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Universal Display (NASDAQ:OLED)
Historical Stock Chart
From Sep 2023 to Sep 2024